1. Home
  2. LXEO vs GROY Comparison

LXEO vs GROY Comparison

Compare LXEO & GROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • GROY
  • Stock Information
  • Founded
  • LXEO 2017
  • GROY 2020
  • Country
  • LXEO United States
  • GROY Canada
  • Employees
  • LXEO N/A
  • GROY N/A
  • Industry
  • LXEO
  • GROY
  • Sector
  • LXEO
  • GROY
  • Exchange
  • LXEO Nasdaq
  • GROY Nasdaq
  • Market Cap
  • LXEO 252.4M
  • GROY 206.6M
  • IPO Year
  • LXEO 2023
  • GROY 2021
  • Fundamental
  • Price
  • LXEO $6.14
  • GROY $1.20
  • Analyst Decision
  • LXEO Strong Buy
  • GROY Strong Buy
  • Analyst Count
  • LXEO 5
  • GROY 4
  • Target Price
  • LXEO $23.80
  • GROY $3.25
  • AVG Volume (30 Days)
  • LXEO 274.8K
  • GROY 996.4K
  • Earning Date
  • LXEO 12-31-2024
  • GROY 11-04-2024
  • Dividend Yield
  • LXEO N/A
  • GROY N/A
  • EPS Growth
  • LXEO N/A
  • GROY N/A
  • EPS
  • LXEO N/A
  • GROY N/A
  • Revenue
  • LXEO N/A
  • GROY $7,764,000.00
  • Revenue This Year
  • LXEO N/A
  • GROY $289.17
  • Revenue Next Year
  • LXEO N/A
  • GROY $102.86
  • P/E Ratio
  • LXEO N/A
  • GROY N/A
  • Revenue Growth
  • LXEO N/A
  • GROY 197.02
  • 52 Week Low
  • LXEO $5.77
  • GROY $1.17
  • 52 Week High
  • LXEO $22.33
  • GROY $2.21
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 35.77
  • GROY 36.60
  • Support Level
  • LXEO $6.78
  • GROY $1.17
  • Resistance Level
  • LXEO $7.40
  • GROY $1.33
  • Average True Range (ATR)
  • LXEO 0.66
  • GROY 0.04
  • MACD
  • LXEO -0.13
  • GROY -0.00
  • Stochastic Oscillator
  • LXEO 1.34
  • GROY 12.50

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About GROY Gold Royalty Corp.

Gold Royalty Corp is a precious metals-focused royalty and streaming company. It offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests.

Share on Social Networks: